Steris Plc operates as a provider of infection prevention and other procedural products and services. The Company offers sterilizers and washers, surgical tables, lights and equipment management systems, and endoscopy accessories.
It is not a pure
waste management business, but it can be included in a waste management ETF as
it is the case with this list.
It is an
interesting business because 75% of revenue is recurring as you have to
sterilize the equipment the company sold to you.
Steris stock analysis – Steris stock price
definitively a growing business with expected growth rates around 5%. Their
revenues should grow in line even if that hasn’t been the case over the last
years. However, a price to earnings ratio in the high 30s, makes this another
good business that is overvalued.
If the company grows earnings at 5% per year, it will take a long time before there is a significant return to shareholders in the form of higher dividends and lower valuations. Perhaps we are in a similar situation to the 1990s. It took the stock more than 20 years to return to previous highs. Given the exuberance surrounding the sector, it is likely to be the case again.
What is interesting
about Steris is that before 2013, it was on nobody’s radar. The market cap was
below $2 billion, before the merger with Synergy Health in 2015 and the stock
didn’t do much since 1999. However, revenues were growing, the dividend had
been increased and all was looking better.
So, this is another indication of what to look for. Plus, in 2012 the price to earnings ratio was around 14, not bad for a stock that doubled revenues and earnings going forward.